MedPath

辽宁绿丹药业有限公司

Ownership
-
Established
1991-04-06
Employees
-
Market Cap
-
Website
www.lnludan.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

99

NMPA:99

Drug Approvals

Troxerutin and Proxyphylline Tablets

Product Name
曲克芦丁羟丙茶碱片
Approval Number
国药准字H21022788
Approval Date
Sep 21, 2020
NMPA

Carbimazole Tablets

Product Name
卡比马唑片
Approval Number
国药准字H21020787
Approval Date
Sep 21, 2020
NMPA

Compound Theophylline and Methylephedrine Tablets

Product Name
复方茶碱甲麻黄碱片
Approval Number
国药准字H21022553
Approval Date
Sep 21, 2020
NMPA

Fenbufen Tablets

Product Name
芬布芬片
Approval Number
国药准字H21020771
Approval Date
Aug 26, 2020
NMPA

Glibenclamide Tablets

Product Name
格列本脲片
Approval Number
国药准字H21021719
Approval Date
Aug 26, 2020
NMPA

Naproxen Tablets

Product Name
萘普生片
Approval Number
国药准字H21020695
Approval Date
Aug 26, 2020
NMPA

Rifampicin Tablets

Product Name
利福平片
Approval Number
国药准字H21020774
Approval Date
Aug 26, 2020
NMPA

Compound Sulfadiazine Tablets

Product Name
复方磺胺嘧啶片
Approval Number
国药准字H21020772
Approval Date
Aug 26, 2020
NMPA

Isosorbide Dinitrate Tablets

Product Name
硝酸异山梨酯片
Approval Number
国药准字H21020693
Approval Date
Aug 26, 2020
NMPA

Piracetam Tablets

Product Name
吡拉西坦片
Approval Number
国药准字H21021725
Approval Date
Aug 26, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.